Register Login

Axogen Inc. (AXGN)

Hartley Lindsey Marie 🟡 adjusted position in 14.4K shares (2 derivative) of Axogen, Inc. (AXGN) at $31.56 ($1.1M) Transaction Date: Dec 08, 2025 | Filing ID: 000160

Full text
Register to leave comments
  • News bot Dec. 10, 2025, 10:20 p.m.

    🔍 Hartley Lindsey Marie (Executive)

    Company: Axogen, Inc. (AXGN)

    Report Date: 2025-12-08

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 25,000
    • Total shares sold: 39,387

    Detailed Transactions and Holdings:

    • Acquired 20,000 shares of Common Stock at $15.22 per share (Direct)
      Date: 2025-12-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 40,763.00 | transaction_form_type: 4
    • Acquired 5,000 shares of Common Stock at $8.2 per share (Direct)
      Date: 2025-12-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 45,763.00 | transaction_form_type: 4
    • Sold 11,533 shares of Common Stock at $31.556 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 34,230.00 | transaction_form_type: 4
    • Sold 2,854 shares of Common Stock at $31.559 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,376.00 | transaction_form_type: 4
    • Sold 20,000 shares of Employee Stock Option (right to purchase) at $15.22 per share (Derivative)
      Date: 2025-12-08 | Code: M | Expires: 2031-11-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 5,000 shares of Employee Stock Option (right to purchase) at $8.2 per share (Derivative)
      Date: 2025-12-08 | Code: M | Expires: 2032-03-16 | equity_swap_involved: 0 | shares_owned_after: 2,500.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on November 1, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on November 1, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.
    • F2: All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.

Search

News categories